Viral Vector Characterization for Cell Therapies

On this page:

Lentiviral quantification
 

Gene modification plays a vital role in numerous cell therapy workflows, such as CAR-T therapies. Lentiviral vectors are currently utilized as highly efficient vehicles for transgene delivery. Given the significant impact of the cell therapy production process on the final product, meticulous control of physical and infectious titers is crucial for efficient development and enhanced product safety.

Discover key methods for lentiviral titer quantification.

Monitor titers with accuracy and precision

Whether produced in-house or via a manufacturing partner, accurate measurement and control of lentiviral titers plays a pivotal role in cell therapy development. By maintaining tight control over lentiviral titers, cell therapy manufacturers can achieve faster process optimization and streamline lot release testing, thus enhancing the efficiency and safety of their products.
 

Regulatory agencies like the FDA and EMA have stringent guidelines for vector copy number (VCN) in cell therapy. Manufacturers must demonstrate that their processes can control VCN and that their final products are safe for use. This involves rigorous optimization during development and scalable solutions for release testing.

Applied Biosystems ViralSEQ Lentivirus Titer solutions for cell therapies

The ViralSEQ lentiviral quantitation system offers a portfolio of real-time and digital PCR assay kits to measure the physical and proviral titer of lentiviral vectors used for genetic modification in cell therapies.

Request a technical consultation

No matter your questions, we are here to help. Our experienced team of scientists and technical specialists is ready to assist you in choosing the right solution and products. Complete this form to start the conversation.
 

 

Analytics Knowledge Hub


Explore the Analytics Knowledge Hub and discover a robust collection of webinars, articles, eBooks, infographics, and other digital resources to help you optimize analytical testing in your bioprocess workflow.
 

Additional bioprocessing resources

As a trusted partner, we are committed to supporting your journey toward innovative biotech solutions.

Accelerate your therapeutic monoclonal antibody development and manufacturing program.                             

Learn, evaluate, connect.   

 

 

 

 

Connect with a Bioprocessing representative or request more info.                                                               

For Research Use or Further Manufacturing. Not for diagnostic use or direct administration into humans or animals.